(f) Inhibition of LRP1 significantly alleviated peribronchial inflammation, airway hyperreactivity, and ASM proliferation in mice with OVA-induced asthma, as well as suppressed OVA-induced increases in FGF2 and phosphorylated ERK expression. This evidence concerns the gene FGF2 and asthma.